POSITION SUMMARY:

TScan Therapeutics is a startup biotech seeking to revolutionize life-changing therapeutics for patients by identifying novel T cells and epitopes. We are looking for a motivated researcher to join our In Vivo Pharmacology team as a Research Associate/Senior Research Associate, supporting the preclinical development of our lead therapeutic TCRs. The ideal candidate should have relevant experience in in vivo pharmacology, mechanism of action and anti-tumor efficacy studies, and enjoy fast-paced, collaborative, and vibrant startup culture. A team player with a sense of urgency will thrive in this role.

RESPONSIBILITIES:

• Participate to in vivo pharmacology efforts and engage in IND-enabling activities.
• Design and execute in vivo preclinical research focused on anti-tumor efficacy and MOA studies for TScan lead TCR candidates.
• Perform standard and complex in vivo procedures, such as tumor implantation and measurements (solid or liquid tumor models), multi route dosing, blood sampling, tissue necropsy.
• Perform standard in vitro and ex vivo work such as cell culture, tumor analysis, flow cytometry, cytokine measurements.
• Work in a team environment, maintain experimental records, analyze data, and prepare study reports.
• Candidate must be familiar with IACUC protocols and guidelines.

REQUIREMENTS:

• For RA level: BS and 0-3+ years of related experience
• For Sr. RA level: BS and 3-5+ years of related experience OR MS and 0-2+ years
• Expertise in in vivo cancer biology, pharmacology, immunology, cell therapy, or related discipline demonstrated by record of relevant scientific achievements
• Expertise in animal handling, tumor implantation and measurement, blood collection, necropsy required
• Proficiency with flow cytometry and cell culture preferred
• Experience isolating PMBCs and T cells, along with experience with functional assays involving primary immune cells (e.g., ELISA, cytotoxicity assays) would be a plus
• Independent thinker with excellent communication skills

About TScan:

TScan Therapeutics was founded in 2018 by a small group of scientists led by Dr. Stephen Elledge (Harvard Medical School/HHMI). TScan is discovering and developing novel TCR-engineered T cell therapies for the treatment of cancer. TScan’s discovery platform is centered around a breakthrough technology that enables the rapid, comprehensive, and genome-wide identification of the peptide antigen targets of T cell receptors. This technology greatly enhances our ability to understand the specific antigens that drive important disease processes, including tumor cell recognition by the immune system, self-reactivity in autoimmune disorders, and acquired immunity in infectious disease. TScan is using the platform in oncology to discover new TCR/target pairs and to rapidly move novel TCRs into clinical development.

Do YOU have the anatomy of a TScanner?

Our talented, compassionate, and intelligent team is what makes TScan a great place to work. Our brand-new offices with approximately 40,000 square feet of premium lab and office space are an environment that supports innovation, camaraderie, and professionalism. We are driven, passionate, fun, flexible and team oriented. Sound like you? Apply today.